263 related articles for article (PubMed ID: 19401596)
1. Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.
Schnell O; Krebs B; Carlsen J; Miederer I; Goetz C; Goldbrunner RH; Wester HJ; Haubner R; Pöpperl G; Holtmannspötter M; Kretzschmar HA; Kessler H; Tonn JC; Schwaiger M; Beer AJ
Neuro Oncol; 2009 Dec; 11(6):861-70. PubMed ID: 19401596
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.
Beer AJ; Haubner R; Sarbia M; Goebel M; Luderschmidt S; Grosu AL; Schnell O; Niemeyer M; Kessler H; Wester HJ; Weber WA; Schwaiger M
Clin Cancer Res; 2006 Jul; 12(13):3942-9. PubMed ID: 16818691
[TBL] [Abstract][Full Text] [Related]
3. Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
Beer AJ; Lorenzen S; Metz S; Herrmann K; Watzlowik P; Wester HJ; Peschel C; Lordick F; Schwaiger M
J Nucl Med; 2008 Jan; 49(1):22-9. PubMed ID: 18077538
[TBL] [Abstract][Full Text] [Related]
4. Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET.
Beer AJ; Niemeyer M; Carlsen J; Sarbia M; Nährig J; Watzlowik P; Wester HJ; Harbeck N; Schwaiger M
J Nucl Med; 2008 Feb; 49(2):255-9. PubMed ID: 18199623
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients.
Beer AJ; Haubner R; Goebel M; Luderschmidt S; Spilker ME; Wester HJ; Weber WA; Schwaiger M
J Nucl Med; 2005 Aug; 46(8):1333-41. PubMed ID: 16085591
[TBL] [Abstract][Full Text] [Related]
6. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.
Beer AJ; Grosu AL; Carlsen J; Kolk A; Sarbia M; Stangier I; Watzlowik P; Wester HJ; Haubner R; Schwaiger M
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6610-6. PubMed ID: 18006761
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
[TBL] [Abstract][Full Text] [Related]
8. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.
Beer AJ; Pelisek J; Heider P; Saraste A; Reeps C; Metz S; Seidl S; Kessler H; Wester HJ; Eckstein HH; Schwaiger M
JACC Cardiovasc Imaging; 2014 Feb; 7(2):178-87. PubMed ID: 24412187
[TBL] [Abstract][Full Text] [Related]
9. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.
Liu S; Liu Z; Chen K; Yan Y; Watzlowik P; Wester HJ; Chin FT; Chen X
Mol Imaging Biol; 2010 Oct; 12(5):530-8. PubMed ID: 19949981
[TBL] [Abstract][Full Text] [Related]
10. Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques.
Saraste A; Laitinen I; Weidl E; Wildgruber M; Weber AW; Nekolla SG; Hölzlwimmer G; Esposito I; Walch A; Leppänen P; Lisinen I; Luppa PB; Ylä-Herttuala S; Wester HJ; Knuuti J; Schwaiger M
J Nucl Cardiol; 2012 Aug; 19(4):775-84. PubMed ID: 22527796
[TBL] [Abstract][Full Text] [Related]
11. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.
Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928
[TBL] [Abstract][Full Text] [Related]
12. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD.
Haubner R; Weber WA; Beer AJ; Vabuliene E; Reim D; Sarbia M; Becker KF; Goebel M; Hein R; Wester HJ; Kessler H; Schwaiger M
PLoS Med; 2005 Mar; 2(3):e70. PubMed ID: 15783258
[TBL] [Abstract][Full Text] [Related]
14. Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD.
Pichler BJ; Kneilling M; Haubner R; Braumüller H; Schwaiger M; Röcken M; Weber WA
J Nucl Med; 2005 Jan; 46(1):184-9. PubMed ID: 15632051
[TBL] [Abstract][Full Text] [Related]
15. Imaging integrin αvβ 3 and NRP-1 positive gliomas with a novel fluorine-18 labeled RGD-ATWLPPR heterodimeric peptide probe.
Wu H; Chen H; Pan D; Ma Y; Liang S; Wan Y; Fang Y
Mol Imaging Biol; 2014 Dec; 16(6):781-92. PubMed ID: 25001194
[TBL] [Abstract][Full Text] [Related]
16. Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography.
Higuchi T; Bengel FM; Seidl S; Watzlowik P; Kessler H; Hegenloh R; Reder S; Nekolla SG; Wester HJ; Schwaiger M
Cardiovasc Res; 2008 May; 78(2):395-403. PubMed ID: 18256073
[TBL] [Abstract][Full Text] [Related]
17. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
18. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
Liu Z; Yan Y; Liu S; Wang F; Chen X
Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
[TBL] [Abstract][Full Text] [Related]
19. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
20. (68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.
Li D; Zhao X; Zhang L; Li F; Ji N; Gao Z; Wang J; Kang P; Liu Z; Shi J; Chen X; Zhu Z
Mol Pharm; 2014 Nov; 11(11):3923-9. PubMed ID: 25093246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]